Novel Developments on Diagnosis and Treatment of Gastrointestinal Cancer
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 380
Special Issue Editor
Special Issue Information
Dear Colleagues,
The rising global burden of gastrointestinal cancers, particularly the increasing incidence among younger populations, is a growing concern. Emerging evidence suggests potential links to lifestyle factors and environmental changes. Current diagnostic methods, including blood tests, ultrasound, and CT scans, often fail to enable early detection, highlighting the urgent need for reliable biomarkers. Furthermore, existing treatment approaches such as surgery, chemotherapy, and radiation therapy remain inadequate in reducing recurrence rates.
To address these challenges, further research is imperative. The development and reassessment of novel and existing diagnostic biomarkers are crucial to improve early detection and treatment outcomes. This Special Issue aims to explore advancements in gastrointestinal cancer diagnosis and therapy, opening new avenues for innovation in the field.
We invite you to contribute original research, systematic reviews, and meta-analyses focusing on novel diagnostic markers, targeted delivery methods, treatment mechanisms, and immunotherapies for gastrointestinal cancers, including gastric, colon, and colorectal cancers.
We look forward to your valuable contributions.
Prof. Dr. Bhaumik Patel
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- colorectal cancer
- gastric cancer
- biomarker
- novel therapy
- immune microenvironment
- gut microbiota
- molecular mechanisms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
